Miltenyi Biotec provides comprehensive systems to pioneering biomedical and clinical researchers in a multitude of therapeutic areas.
The automated CliniMACS® Cell Separation System
is based on proven magnetic separation methodology, the renowned MACS®
Technology. In combination with high quality MACS GMP
and CryoMACS® Products
, the system enables consistent generation of cellular products for a wide range of clinical applications.
In addition to the CliniMACS System for cell-based applicationss, outside of the USA, the TheraSorb™ Therapeutic Apheresis System
is available for plasmapheresis, i.e., the selective removal of pathogenic substances from the patient’s plasma by affinity chromatography.
Our clinical development team coordinates a worldwide clinical trial program
in close cooperation with leading investigators to test the therapeutic utility of Miltenyi Biotec’s clinical products.
Areas of activity include all aspects of the product portfolio with an emphasis on hemato-oncological, infectious, cardiovascular, immunological, and other indications.
Miltenyi Biotec supports a number of clinical trials in indications that range from hemato-oncology to autoimmunity.
Stem cell enrichment and T cell depletion represent the primary modes of graft engineering offered by Miltenyi Biotec using MACS Technology.
Immunotherapy for clinical research
By combining the flexible technology of the CliniMACS System with the MACS GMP product line, Miltenyi Biotec offers customized solutions to clinical-grade separation of virtually any cell type.
Autologous stem cells are at the forefront of tissue regeneration approaches in clinical settings. Miltenyi Biotec’s portfolio of clinical-grade technologies and reagents forms the basis for successful enrichment of hematopoietic and non-hematopoietic stem cells.
Flexibility is the foremost feature of the CliniMACS® System, which provides a platform for separating almost any cell type including stem cells, monocytes, dendritic cells, natural killer cells, as well as B and T lymphocytes.
MACS Clinical Flow Cytometry
MACS® Clinical Flow Cytometry
- CE-IVD quality grade – manufactured according to quality management system ISO 13485
- Compliance – fulfilling essential regulatory requirements for In-Vitro Diagnostic Medical Devices (Directive 98/79/EC)
- Reliability – optimized for quality control of cellular products in translational workflows
MACS GMP Products
MACS® GMP Products
Adherence to GMP guidelines is mandatory for applications involving cellular therapy. Miltenyi Biotec ensures GMP quality in all of its products that have been developed for clinical use.
CryoMACS Freezing Products
CryoMACS® Freezing Products
CryoMACS® Freezing Bags consist of a freezing bag and an overwrap bag for extra safety and reliability and are available for routine clinical use. CryoMACS DMSO 10 (EP, ESP) is manufactured in accordance with GMP guidelines.
Apoptotic cell removal
Apoptotic cell removal
Improve sperm fertilization potential by specific depletion of apoptotic and dead spermatozoa.
TheraSorb™ Therapeutic Apheresis
TheraSorb™ Therapeutic Apheresis may be helpful for the treatment of diseases associated with pathogenic substances in the patient’s plasma.